Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

6.350 -0.040 (-0.63%)
Streaming Delayed Price Updated: 9:45 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
7 Stable Stocks for 50% Returns by Early 2025
These 7 stable stocks also offer 50% returns according to analysts according to analysts tasked with following their respective industries. 
Via InvestorPlace
Treace to Report First Quarter 2024 Financial Results
Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Recap: Treace Medical Concepts Q4 Earnings
 
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Earnings Preview For Treace Medical Concepts
 
Via Benzinga
6 Analysts Assess Treace Medical Concepts: What You Need To Know
 
Via Benzinga
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
Company Previews New SpeedPlate™ Configurations, Announces Full Commercial Release of its Micro-Lapiplasty™ System and Limited Clinical Release of its Mini-Adductoplasty™ System and RedPoint™... 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
Company to Present at J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 3:45 pm Pacific Time 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Analyst Ratings for Treace Medical Concepts
 
Via Benzinga
The Latest Analyst Ratings for Treace Medical Concepts
 
Via Benzinga
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
Tuesday, January 9, 2024, at 3:45 pm Pacific Time 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Friday. Following the market opening Friday, the Dow traded up 0.37% to 34,016.77 while the NASDAQ rose 0.74% to... 
Via Benzinga
Topics Stocks
Treace Medical Concepts Disappoints On Q3 Results, Lowers FY23 Guidance
Treace Medical Concepts Inc (NASDAQ: TMCI) shares are trading lower after the company reported worse-than-expected third-quarter financial results and lowered full-year 2023 revenue 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
Treace to Present at Stifel 2023 Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Third Quarter 2023 Financial Results
Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 225 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.